Description: The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 74.00 | 0.00 | 74.00 |
| Stock non-US | 25.45 | 0.00 | 25.45 |
| Cash | 0.55 | 0.00 | 0.55 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.78 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 74.72 | 90.74 |
| Europe Developed | 16.36 | 6.15 |
| United Kingdom | 4.60 | 2.07 |
| Japan | 4.33 | 0.50 |
| Australasia | 0.00 | 0.08 |
| Asia Emerging | 0.00 | 0.34 |
| Asia Developed | 0.00 | 0.03 |
| Africa/Middle East | 0.00 | 0.10 |